@Wafflebob Also this "Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age." https://t.co/etONqKzWO
4,412 followers
600 followers
New Short Report: TMEM106B, a FTLD modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III https://t.co/nKgUFylnlh
333 followers
TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of… https://t.co/Oos43hq6ts
1,352 followers
TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of… https://t.co/ExF8b1ulVh